Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | GPR119 | Q8TDV5 | 3/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | PREP | P48147 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28428311 | 0.81 | CHRM2 (0.39) | USP2SMN1; SMN2CHRM2CHRM1CHRM3 | |
| SCHEMBL19892750 | 0.80 | CHRM2 (0.34) | USP2SMN1; SMN2CHRM2CHRM1CHRM3 | |
| SCHEMBL30121408 | 0.80 | CHRM2 (0.34) | USP2SMN1; SMN2CHRM2CHRM1CHRM3 | |
| SCHEMBL28842147 | 0.79 | NR1H2 (0.34) | USP2SMN1; SMN2CHRM2CHRM1CHRM3 | |
| SCHEMBL27510719 | 0.76 | CTSK (0.33) | USP2SMN1; SMN2CHRM2CHRM1CHRM3 | |
| SCHEMBL27721708 | 0.76 | PDE4B (0.36) | CHRM2CHRM1CHRM3KMT2ANR1H2 | |
| SCHEMBL28102330 | 0.75 | LMNA (0.36) | SMN1; SMN2CHRM2CHRM1CHRM3MEN1 | |
| SCHEMBL4772238 | 0.73 | KMT2A (0.38) | MEN1KMT2ACTSKRECQLNR1H2 | |
| SCHEMBL23193927 | 0.72 | CHRM2 (0.47) | USP2SMN1; SMN2CHRM2CHRM1CHRM3 | |
| SCHEMBL27309746 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106117119-A | The synthetic method of medicine intermediate 1-tertbutyloxycarbonyl-2-picoline | 无锡乾浩生物医药有限公司 | 2016-11-16 | — | — | CN | claimed |
| US-20250214964-A1 | COMPOUNDS DERIVED FROM 4-AMINO-N-(4-AMINOPHENYL) BENZAMIDE AND ANALOGUES AND USE THEREOF | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2025-07-03 | — | — | US | disclosed |
| CN-106117119-A | The synthetic method of medicine intermediate 1-tertbutyloxycarbonyl-2-picoline | 无锡乾浩生物医药有限公司 | 2016-11-16 | — | — | CN | disclosed |
| CN-106117119-A | The synthetic method of medicine intermediate 1-tertbutyloxycarbonyl-2-picoline | 无锡乾浩生物医药有限公司 | 2016-11-16 | — | — | CN | disclosed |
| CN-106117119-A | The synthetic method of medicine intermediate 1-tertbutyloxycarbonyl-2-picoline | 无锡乾浩生物医药有限公司 | 2016-11-16 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250214964-A1 | COMPOUNDS DERIVED FROM 4-AMINO-N-(4-AMINOPHENYL) BENZAMIDE AND ANALOGUES AND USE THEREOF | ABAT, AADAT, AADAC | USP2 4619/4885SMN1; SMN2 3673/4885CHRM2 4477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.